GAO on “IP” and drug innovation

December 19, 2006

Speaking here of drugs Congress likes– patented pharmaceuticals– the GAO says:

Intellectual property protections are designed to help encourage innovation by providing financial incentives to engage in research and development efforts.

but, according to some experts interviewed by GAO

intellectual property protections enable companies to earn significant profits while reducing the incentive to develop more innovative drugs.

Nothing really new here. GAO wasn’t asked to provide any recommendations.¬† Full report is here.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: